NEW YORK, March 19 QED International Associates Inc.,administrator for the HealthShares(TM) Indexes, a series of 20 underlyingindexes for the HealthShares(TM) Exchange-Traded Funds, today announced thequarterly rebalancing of the Indexes.
The following securities will be added and deleted in the Indexeseffective before the opening of trading on NYSE Arca March 24, 2008.
The rebalanced Indexes, including the rebalanced Index Shares, are basedon the closing prices as of March 14, 2008.
In accordance with the Exemptive Order, a complete list of theconstituents reflecting the rebalancing will be posted atwww.healthsharesinc.com/content/view/53/274/.
About QED International Associates
QED International, based in New York, is a leading financial industryconsulting firm specializing in quantitative modeling and the design,development and maintenance of indexes and Exchange Traded Funds. For moreinformation, visit the company's website at www.qedinternational.comAutoimmune-Inflammation Index (HHA) Drop GW Pharmaceuticals, Inc (LSE: GWP.L) Human Genome Sciences (Nasdaq: HGSI) Ligand Pharmaceuticals, Inc. (Nasdaq: LGND) Add Fornix Biosciences N.V. (Amsterdam: FORBI.AS) Meda AB (SHSE1: MEDA A) Mitsubishi Tanabe Pharma Corporation (TSE: 4508) Cancer Index (HHK) Drop Shire PLC (Nasdaq: SHPGY) Add Ark Therapeutics Group Plc (LSE: AKT.L) Cardio Devices Index (HHE) Drop Biosphere Medical, Inc. (Nasdaq: BSMD) Add Zoll Medical Corp. (Nasdaq: ZOLL) Cardiology Index (HRD) Drop Encysive Pharmaceuticals, Inc. (Nasdaq: ENCY) Human Genome Sciences, Inc (Nasdaq: HGSI) Vical, Inc (Nasdaq: VICL) Add Mitsubishi Tanabe Pharma Corporation (TSE: 4508) Sangamo BioSciences Inc (Nasdaq: SGMO) Sciele Pharma, Inc. (Nasdaq: SCRX) Composite Index (HHQ) Drop Advanced Medical Optics, Inc. (NYSE: EYE) Align Technology Inc. (Nasdaq: ALGN) Array Biopharma Inc. (Nasdaq: ARRY) ArthroCare Corp. (Nasdaq: ARTC) Endo Pharmaceuticals Hldgs. (Nasdaq: ENDP) Fresenius Medical Care AG (XETRA: FME.DE) GEDEON RICHTER RT (XETRA: R1G1.DE) GENMAB A/S (Copenhagen: GEN.CO) H. LUNDBECK A/S (Copenhagen: LUN.CO) Human Genome Sciences (Nasdaq: HGSI) Imclone Systems (Nasdaq: IMCL) Inverness Medical Innovations (Amex: IMA) Invitrogen Corp. (Nasdaq: IVGN) Medarex Inc. (Nasdaq: MEDX) Medicis Pharmaceutical (NYSE: MRX) Mentor Corp. (NYSE: MNT) ONYX Pharmaceuticals Inc. (Nasdaq: ONXX) PDL BioPharma, Inc. (Nasdaq: PDLI) Pharmion Corp. (Nasdaq: PHRM) Progenics Pharmaceuticals Inc. (Nasdaq: PGNX) Regeneron Pharmaceuticals (Nasdaq: REGN) Respironics Inc. (Nasdaq: RESP) Sepracor Inc. (Nasdaq: SEPR) Theravance Inc. (Nasdaq: THRX) United Therapeutics Corp. (Nasdaq: UTHR) Valeant Pharmaceuticals Int'l (NYSE: VRX) Vertex Pharmaceuticals (Nasdaq: VRTX) Add Adolor Corp. (Nasdaq: ADLR) ALLOS THERAPEUTICS INC. (Nasdaq: ALTH) Alnylam Pharmaceuticals Inc. (Nasdaq: ALNY) Alpharma Inc. (NYSE: ALO) Altus Pharmaceuticals Inc. (Nasdaq: ALTU) AMAG Pharmaceuticals Inc. (Nasdaq: AMAG) ANGIOTECH PHARMACEUTICALS (Nasdaq: ANPI) Ark Therapeutics (LSE: AKT.L) Bavarian Nordic A/S (Copenhagen: BAVA.CO) Caraco Pharmaceutical Laboratories Ltd. (Amex: CPD) Cardiome Pharma Corp. (Nasdaq: CRME) Coventry Health Care Inc. (NYSE: CVH) CRUCELL-ADR (Nasdaq: CRXL) CUBIST PHARMACEUTICALS INC. (Nasdaq: CBST) Discovery Laboratories Inc. (Nasdaq: DSCO) Eisai Co. Ltd. (TSE: 4523.T) Encysive Pharmaceuticals Inc. (Nasdaq: ENCY) Enzo Biochem Inc. (NYSE: ENZ) ENZON PHARMACEUTICALS INC. (Nasdaq: ENZN) Exelixis Inc. (Nasdaq: EXEL) Flamel Technologies (Nasdaq: FLML) Illumina Inc. (Nasdaq: ILMN) Incyte Cor